Vectormune FP-LT+AE (Canada)

This page contains information on Vectormune FP-LT+AE for veterinary use.
The information provided typically includes the following:

Vectormune FP-LT+AE Indications
Warnings and cautions for Vectormune FP-LT+AE
Direction and dosage information for Vectormune FP-LT+AE

Vectormune FP-LT+AE

This treatment applies to the following species:

Chickens

Company: Ceva Animal Health

AVIAN ENCEPHALOMYELITIS-FOWL POX-LARYNGOTRACHEITIS VACCINE

Live virus, live fowl pox vector

Description

Vectormune^® FP-LT+AE contains a genetically engineered, live virus vaccine for the vaccination of chickens as an aid in the prevention of fowl pox and laryngotracheitis. The vaccine also contains a conventional live virus for vaccination as an aid in the prevention of avian encephalomyelitis. The fowl pox vaccine has been genetically engineered to contain and express key protective laryngotracheitis virus antigens.

Vectormune FP-LT+AE Caution

Federal regulations prohibit repackaging or sale of the contents of this package in fractional units. Do not accept if seal is broken.

Warning

Store vaccine at 2 - 7°C (35 - 45°F). Do not vaccinate within 21 days of slaughter. Use entire contents immediately after rehydrating. Burn containers and all unused contents. Contains gentamicin and amphotericin B as preservatives. For veterinary use only.

Vectormune FP-LT+AE Indications

Administer by wing web to healthy, susceptible chickens at least eight weeks old but at least four weeks prior to the start of egg production. Chickens receiving this vaccine must not have been previously vaccinated with a fowl pox vaccine.

Dosage and Administration

Remove seal and stopper from vaccine vial and diluent vial. Pour entire contents of diluent vial into vaccine vial, insert stopper, and shake well. The vaccine is ready for use and should be used within one hour. Hold each individual bird and spread the wing with the underside facing up. Dip the two-pronged wing web applicator into the vaccine so that the grooves fill with liquid and deliver 0.01 ml per bird. Insert the double-pronged applicator into the web portion of the wing avoiding blood vessels, muscle, and bone. Seven to ten days after vaccination, observe several chickens for evidence of “takes” that include swelling and/or scab formation at the site of injection.

Patent No. U.S. 6312696

10 x 1000 DOSES

Manufactured By: BIOMUNE CO., Lenexa, Kansas 66215 USA

Phone (913) 894-0230

U.S. Vet Lic. No. 368

Distributed By: Ceva Animal Health, Guelph, Ontario N1K 1E8

814CANEF

CPN: 12211000

CEVA ANIMAL HEALTH INC.
150 RESEARCH LANE, SUITE 225, GUELPH, ON, N1G 4T2

Telephone:		519-650-9570
Toll-Free:		800-510-8864
Fax:		519-650-9576
Website:		www.ceva-canada.ca
Email:		service.canada@ceva.com

THIS SERVICE AND DATA ARE PROVIDED "AS IS". Animalytix assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the Animalytix service and data. See the Terms of Use for further details.